Stay updated on Avatrombopag for CTC-Induced Thrombocytopenia Clinical Trial
Sign up to get notified when there's something new on the Avatrombopag for CTC-Induced Thrombocytopenia Clinical Trial page.

Latest updates to the Avatrombopag for CTC-Induced Thrombocytopenia Clinical Trial page
- Check4 days agoChange DetectedA sitewide banner announces NIH website updates and a terminology change related to Executive Order 14434. The site revision label advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe footer identifies the ClinicalTrials.gov release as v3.7.1 instead of v3.7.0. The study record remains inaccessible with a 403 Forbidden error.SummaryDifference0.2%

- Check32 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study details, indicating an access restriction to the study record. This blocks viewing the study content.SummaryDifference17%

- Check39 days agoChange DetectedThe page revision was updated from v3.6.6 to v3.7.0. This reflects a minor update to the study record’s metadata rather than substantive changes to the trial data or eligibility criteria.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page's revision label was updated from v3.6.5 to v3.6.6, indicating a newer version of the ClinicalTrials.gov record.SummaryDifference0.0%

- Check74 days agoChange DetectedThe revision tag updated from v3.6.4 to v3.6.5, indicating a small site update; no impact on study data or page functionality.SummaryDifference0.0%

Stay in the know with updates to Avatrombopag for CTC-Induced Thrombocytopenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avatrombopag for CTC-Induced Thrombocytopenia Clinical Trial page.